A prospective open-label study to determine safety and efficacy of a pre-emptive treatment protocol elderly veteran population
Latest Information Update: 24 Feb 2023
At a glance
- Drugs Glecaprevir/pibrentasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
Most Recent Events
- 17 Feb 2023 Results published in the Transplantation Proceedings
- 03 Aug 2022 New trial record
- 08 Jun 2022 Results presented at the 2022 American Transplant Congress